Melanoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 years or older
- People who have been diagnosed with metastatic (spreading) melanoma, a type of skin cancer that has spread to other parts of the body
- People who are planning to start their first course of immunotherapy treatment for this condition
- People who are willing and able to sign a consent form agreeing to take part in the study
Who may not be able to join:
- People under the age of 18
- People who are unable to provide informed consent (for example, due to a condition affecting their ability to understand and agree to participation)
- People who have any other condition that, in the treating doctor's judgement, would prevent them from safely taking part or from having samples collected during the study (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 015879287
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Overall Response Rate (ORR) to First-Line Immunotherapy
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.